HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Lupin’s arm collaborates with PolyPeptide
Dec-12-2025

Lupin’s subsidiary -- Lupin Manufacturing Solutions (LMS) has collaborated with PolyPeptide Group AG (PolyPeptide), a specialized, global CDMO for peptide-based active pharmaceutical ingredients. This partnership aims to enhance supply chain resilience, improve operational efficiency, and accelerate readiness for the rapidly expanding global peptides market. It also advances next-generation peptide therapeutics, including those for metabolics, supporting the long-term strategic growth of both organizations.

As part of this collaboration, both the companies will work towards, expanding sourcing options and fortifying peptide supply chains to meet rising global demand for peptide APIs, including for metabolic disease therapies; integrating procurement and supply planning; and ensuring unwavering quality and reliability and delivering superior service globally.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

  RELATED NEWS >>